Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New opportunities for development of safe, effective live virus vaccines.

The Yale journal of biology and medicine - 1 Jan 2000

Chanock R M

Abstract excerpt

Effective vaccines are not available for most viral diseases. This situation may soon change when the full force of contemporary molecular biology is applied to immunoprophylaxis. In certain viral diseases, particularly those affecting the respiratory and gastrointestinal tracts, live attenuated vaccines are needed to confer effective protection. Until now the major obstacle to success has been genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cloning, Molecular
Share to Genes, Viral
Share to Influenza A virus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Poliovirus

Share to Recombination, Genetic

Share to Transfection

Share to Vaccines, Attenuated

Source

Open in PubMed Open full text

Identifiers

PMID: 6295011
PMCID: PMC2596472

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New opportunities for development of safe, effective live virus vaccines.PMID 6295011Read ↗

Rationalizing the development of live attenuated virus vaccinesSemantic proximity Read ↗

Mimicking live flavivirus immunization with a noninfectious RNA vaccineSemantic proximity Read ↗

Reverse genetics approaches for live-attenuated vaccine development of infectious bursal disease virusSemantic proximity Read ↗

Replication-defective viruses as vaccines and vaccine vectors.Semantic proximity Read ↗

Toward novel vaccines and therapies based on negative-strand RNA viruses.Semantic proximity Read ↗

Genetically engineered live attenuated influenza A virus vaccine candidates.Semantic proximity Read ↗

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenzaSemantic proximity Read ↗

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Semantic proximity Read ↗

Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating VaccinesSemantic proximity Read ↗

Live attenuated AIDS viruses as vaccines: promise or peril?Semantic proximity Read ↗

Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine StrainsSemantic proximity Read ↗

Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.